Bold Clinical Analysis:

Landmark, peer-reviewed analysis adds clinical relevance for your everyday practice

1. Results reported by sites healthy and plaque-free—as opposed to whole-mouth plaque/gingivitis reduction data—allow you to easily set targets for your practice
2. This analysis reviewed data on the additive benefits of LISTERINE^® from randomized, observer-blinded, placebo-controlled studies, including both published and unpublished data
3. Evidence was drawn from a larger-than-usual population of N>5000 subjects; single studies have an average of 163 subjects

A most robust collection of data 

• 1 landmark analysis: enabled broader, more clinically relevant conclusions

Analysis compared the results of 2 treatment groups

Control group

• Mechanical methods (MM) alone
• 2562 patients

Experimental group

• MM + LISTERINE®
• 2544 patients

Sitewise analysis evaluated efficacy at multiple sites per tooth across the entire mouth

Plaque index (PI): 6 sites per tooth

• Plaque-free sites were defined as those with small pieces of plaque (1) or no plaque (0), based on the PI score

Modified gingival index (MGI): 4 sites per tooth

• Healthy sites were defined as those with mild (1) to no (0) inflammation, based on the MGI scores

LISTERINE® users were more likely to have a cleaner, healthier mouth vs. MM alone

LISTERINE^® users had more plaque-free sites and more healthy sites—even in the hardest-to-reach areas of the mouth